Gapping down
In reaction to disappointing earnings/guidance: ACI -2.8% (announced that lower-than-planned shipment levels in the Powder River Basin and reduced production levels at the Mountain Laurel complex in Appalachia will impact its fourth quarter 2013 financial results),. DB -2.8%, PETS -1.8%, SAP -1.4%, AGU -1.2%, RF -0.7%.
M&A news: PATH -7.3% (NuPathe enters into agreement to be acquired by Teva (TEVA) for $3.65 per share in cash and rights to receive additional cash payments of up to $3.15 per share).
Brazil stocks showing weakness following Q4 China GDP data: OIBR -3.2%, SID -3.1%, GGB -2.7%, PBR -2.6%, RIO -2.3%, ERJ -2.3%, CBD -2%, VIV -1.9%, BRFS -1.6%, VALE -1.4%,
Other news: AMRN -20.7% (announces FDA review division response to ANCHOR SPA agreement reinstatement request; does not plan to re-instate the ANCHOR SPA agreement) OSBC -7.3% (files for $70 mln offering of common stock, BIOL -5.6% (files for $12.5 mln mixed securities shelf offering), PRTA -2.3% ( files for offering of ~3.18 mln shares of common stock by selling shareholders), XLRN -1.7% (commences public offering of $100 mln of its common stock), MDLZ -0.9% (Mondelez Int'l adds Nelson Peltz to Board of Directors; CNBC reports that Nelson Pelz will not be pushing for Pepsi (PEP)/MDLZ transaction, now that he's on MDLZ board ), MW -0.9% (Jos. A. Bank Board of Directors rejects unsolicited tender offer from Men's Warehouse), TWTR -0.3% (Twitter product chief plans to step down, according to reports), .
Analyst comments: CEO -4.5% (downgraded to Market Perform from Outperform at Bernstein ), FEYE -2.3% (downgraded to Neutral from Overweight at JPMorgan), DDD -1.9% (downgraded to Neutral from Outperform at Credit Suisse), AEG -1.5% (downgraded to Neutral from Overweight at HSBC ), ING -1.4% (downgraded to Underweight from Neutral at HSBC), TWC -1.3% (downgraded to Hold from Buy at Needham), VOLC -1.2% (downgraded to Mkt Perform from Outperform at Raymond James ), LULU -1% ( downgraded to Neutral from Strong Buy at ISI Group), TROW -0.8% (downgraded to Neutral from Buy at Citigroup), SBUX -0.8% (removed from Conviction Buy list at Goldman), NE -0.8% (downgraded to Equal Weight from Overweight at Morgan Stanley ), CVD -0.5% (downgraded to Neutral from Buy at Goldman), TGT -0.4% (downgraded to Underperform from Market Perform at Cowen ), XOM -0.4% (Exxon Mobil downgraded to Neutral from Buy at BofA)